3 employees
Prolevi Bio develops a delayed release thyroid hormone formulation mimicking the circadian rhythm improving long-term side effects.
2021
$281K
from 1 investors over 1 rounds
Prolevi Bio raised $281K on September 14, 2022
Investors: Almi Invest